Immunogenicity and Safety of a Quadrivalent Influenza Vaccine in Population Aged 3 Years and Older in Chile and the Philippines: A Phase 3, Non-Inferiority, Double-Blind, Randomized Controlled Clinical Trial.
Wanqi YangGonzález PaQianqian XinMari Rose De Los ReyesRalph Elvi VillalobosCharissa Fay Corazon Borja-TaboraNancy Nazaire BermalAlexis M KalergisDan YuWenbin WuSusan M BuenoLiqun HuoMario Calvonull Qinf Study GroupGang ZengJing LiPublished in: Vaccines (2024)
The immunogenicity of Sinovac QIV was non-inferior to that of the comparator QIV in these populations aged 3 years and older, and safety was comparable.